Genomma Lab Internacional SAB de CV
BMV:LABB

Watchlist Manager
Genomma Lab Internacional SAB de CV Logo
Genomma Lab Internacional SAB de CV
BMV:LABB
Watchlist
Price: 17.11 MXN -1.55% Market Closed
Market Cap: Mex$17.1B

Operating Margin

21.5%
Current
Improving
by 1.2%
vs 3-y average of 20.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
21.5%
=
Operating Income
Mex$3.9B
/
Revenue
Mex$18.2B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
21.5%
=
Operating Income
Mex$3.9B
/
Revenue
Mex$18.2B

Peer Comparison

Country Company Market Cap Operating
Margin
MX
Genomma Lab Internacional SAB de CV
BMV:LABB
16.8B MXN
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
530.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
281.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
213.4B GBP
Loading...
CH
Novartis AG
SIX:NOVN
223B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
267.6B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.1B USD
Loading...
FR
Sanofi SA
PAR:SAN
96.5B EUR
Loading...

Market Distribution

In line with most companies in Mexico
Percentile
70th
Based on 277 companies
70th percentile
21.5%
Low
-411.5% — 5.1%
Typical Range
5.1% — 21.5%
High
21.5% — 838%
Distribution Statistics
Mexico
Min -411.5%
30th Percentile 5.1%
Median 11.3%
70th Percentile 21.5%
Max 838%

Genomma Lab Internacional SAB de CV
Glance View

Market Cap
17.1B MXN
Industry
Pharmaceuticals

Nestled amid the dynamic landscape of the Mexican pharmaceutical and personal care market, Genomma Lab Internacional SAB de CV has carved a distinct niche for itself since its inception in 1996. The company, recognized for its innovative approach to marketing and product distribution, operates with a dual business model that focuses both on over-the-counter (OTC) medications and a slew of personal care products. This strategic diversification has enabled Genomma Lab to tap into a broad array of consumer needs, expanding its reach beyond the confines of Mexico to a wide array of markets across the Latin American region and beyond. By leveraging a robust distribution network, which includes traditional retailers and modern trade channels, Genomma ensures that its products – from headache remedies to skincare solutions – are easily accessible to consumers, thereby driving consistent revenue growth. Central to Genomma Lab's success is its ability to blend strategic marketing prowess with an agile supply chain. The company's marketing campaigns are meticulously crafted, often highlighting the efficacy and trustworthiness of its products, which resonates well with a cost-sensitive yet quality-oriented consumer base. Furthermore, Genomma Lab thrives on an innovative product pipeline that sees continual introductions and adaptations in response to changing market demands. This commitment to innovation is complemented by cost efficiency in its operations, allowing the company to maintain competitive pricing. With an entrenched brand presence and a solid track record of adaptability, Genomma Lab continues to bolster its market position, focusing on both organic growth and strategic alliances to propel its evolution in the global marketplace.

LABB Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
21.5%
=
Operating Income
Mex$3.9B
/
Revenue
Mex$18.2B
What is Genomma Lab Internacional SAB de CV's current Operating Margin?

The current Operating Margin for Genomma Lab Internacional SAB de CV is 21.5%, which is above its 3-year median of 20.3%.

How has Operating Margin changed over time?

Over the last 3 years, Genomma Lab Internacional SAB de CV’s Operating Margin has increased from 19.7% to 21.5%. During this period, it reached a low of 19.3% on Mar 31, 2023 and a high of 21.6% on Jun 30, 2025.

Back to Top